Investors need to pay close attention to THC stock based on the movements in the options market lately.

Ford Motor (NYSE:F) is scheduled to announce its earnings on Wednesday, July 30, 2025. The consensus predicts earnings of approximately $0.33 per share, a decrease from $0.47 per share in the same quarter last year, while revenues are expected to be around $43.93 billion, reflecting a 2% decline compared to the previous year.

GETTYSBURG, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $11.6 million, or $1.11 diluted earnings per share, for the three months ended June 30, 2025 compared to net income of $11.3 million, or $1.32 diluted earnings per share, for the three months ended June 30, 2024 and compared to net loss of $272 thousand, or $0.03 diluted loss per share, for the three months ended March 31, 2025. Financial results for the three months ended March 31, 2025 …

CORTE MADERA, Calif.--(BUSINESS WIRE)--RH (NYSE: RH) announced today the opening of RH Montreal, The Gallery at Royalmount, an immersive retail experience seamlessly integrating luxury home furnishings collections from RH Interiors, Modern and Outdoor with rare art, antiques and artifacts from across the globe. The brand's first-ever Design Gallery in Québec features a dramatic glass-encased Rooftop Restaurant & Park offering a thoughtfully curated menu of enduring classics with the freshes.

Bumble (BMBL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Hot take bearishness can make a mess for shareholders. Many issues need human time (not machine time) for proper analysis. I wrote about this recently for a biotech.

Bonds remain attractive in 2025 with the yield on the 10-year treasury running in the low-to-mid 4% range. However, as slow as the pace may be, the FOMC is on track to begin reducing interest rates this year and bring them back to a “normalized” level over time.

NEW YORK--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank, N.A., has been appointed by Youlife Group Inc. (Youlife) as depositary bank for its American Depositary Receipt (ADR) program. The appointment follows after Youlife International Holdings Inc., a blue-collar lifetime service provider in China, and Distoken Acquisition Corporation, a special purpose acquisition company, completed their business combination on July 9, 2025. The American Depositary Shares (ADS) of the combin.

NEW YORK--(BUSINESS WIRE)--iHeartMedia, Inc. (NASDAQ: IHRT) announced today that on Monday August 11th, 2025, it will issue financial results for the quarter ending June 30, 2025. The company will conduct a conference call at 4:30 p.m. (ET), following the release of its earnings announcement, to discuss its financial results and business outlook. A live audio webcast of the call will be available on the Investors homepage of iHeartMedia's website (https://investors.iheartmedia.com/) beginning a.

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Westwood Insurance Agency LLC (“Westwood”), the preeminent insurance agency for the homebuilding industry, announced today a new collaboration with Legend Homes, a Texas-based builder ranked as a top 40 home builder in the United States1. Through its relationship with Westwood, Legend Homes will be able to embed an offer of home insurance early in its customers' homebuying journey. Within 24 hours after homebuyers sign a contract to purchase a new home,.

Tesla, Inc. has underperformed the S&P 500 on an absolute basis, while also experiencing significant volatility. The exciting narrative is running out of steam, which is resulting in lower momentum exposure for the stock. TSLA is no longer a high-growth stock but does not achieve margins akin to a mature company.

PLANT CITY, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) celebrated today the grand opening of its newest facility, Sysco Tampa Bay, the ninth site opened in the past year as the company continues its global growth and expansion.

Las Vegas, Nevada, July 24, 2025 (GLOBE NEWSWIRE) -- High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller and Fruta , today announced that the Company will host a conference call regarding its second quarter 2025 financial results and business update on August 12, 2025 at 4:30 PM Eastern Time (ET).

Strong software bookings, M&A, and AI to drive solid revenue growth. Recurring software mix and AI gain support margin expansion. Valuation below the historical average offers room for multiple re-rating.

WDC, FLS, KAR, AU and JBL show strong relative price strength as trade deals and economic data fuel the S&P 500 rally.

NUE is expected to post strong Q2 as tariff-fueled steel price spikes and higher volumes are likely to lift performance.

West Bancorp (WTBA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.31 per share a year ago.

LITTLE ROCK, Ark. , July 24, 2025 /PRNewswire/ -- Tickets for the Simmons Bank Championship presented by Stephens—a PGA TOUR Champions playoff event—are now on sale to the public.

JUNO BEACH, Fla. , July 24, 2025 /PRNewswire/ -- The board of directors of NextEra Energy, Inc. (NYSE: NEE) declared a regular quarterly common stock dividend of $0.5665 per share.

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohorts Darovasertib has received U.S. FDA Breakthrough Therapy Designation for use in neoadjuvant uveal melanoma for subjects requiring enucleation Initiated a multi-site, global randomized Phase 3 neoadjuvant registrational trial in primary uveal melanoma (OptimUM-10) in Q3 2025 SOUTH SAN FRANCISCO, Calif. , July 24, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that results from a multi-site global Phase 2 study of neoadjuvant darovasertib in primary uveal melanoma was accepted for a Proffered Paper oral presentation …